Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia?

被引：16
|
作者：
Styczynski, J [1 ]
Wysocki, M [1 ]
机构：
[1] Med Univ, Dept Pediat Hematol & Oncol, Bydgoszcz, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 05期
关键词：
D O I：
10.1200/JCO.2004.99.274
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：963 / 964
页数：2
相关论文
共 50 条
  • [1] IN-VITRO DRUG-RESISTANCE PROFILE - STRONGEST PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    KASPERS, GJL
    VEERMAN, AJP
    PIETERS, R
    VANZANTWIJK, CH
    VANWERING, ER
    VANDERDOESVANDENBERG, A
    BLOOD, 1994, 84 (10) : A516 - A516
  • [2] Prognostic value of drug resistance profiles in childhood acute lymphoblastic leukemia
    Den Boer, ML
    Pieters, R
    Kazemier, KM
    Harms, DO
    Janka-Schaub, GE
    Van der Does-Van den Berg, A
    Kamps, WA
    Van Wering, ER
    Kaspers, GJL
    Veerman, AJP
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 275 - 275
  • [3] Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia
    Pogorzala, Monika
    Kubicka, Malgorzata
    Rafinska, Beata
    Wysocki, Mariusz
    Styczynski, Jan
    ANTICANCER RESEARCH, 2015, 35 (10) : 5667 - 5670
  • [4] Ex vivo drug resistance profile in childhood acute myelogenous leukemia:: No drug is more effective in comparison to acute lymphoblastic leukemia
    Styczynski, J
    Wysocki, M
    Debski, R
    Juraszewska, E
    Malinowska, I
    Stanczak, E
    Ploszynska, A
    Stefaniak, J
    Mazur, B
    Szczepanski, T
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1843 - 1848
  • [5] Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan
    Chen, Shih-Hsiang
    Yang, Chao-Ping
    Jaing, Tang-Her
    Hung, Iou-Jih
    Shih, Lee-Yung
    Ho, Pei-Chun
    Lee, Wen-I
    Huang, Jing-Long
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1536 - 1542
  • [6] In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia
    Kaspers, GJL
    Veerman, AJP
    Pieters, R
    VanZantwijk, CH
    Smets, LA
    VanWering, ER
    DenBerg, AV
    BLOOD, 1997, 90 (07) : 2723 - 2729
  • [7] In Vitro Drug Testing of Barasertib in Childhood Acute Lymphoblastic Leukemia
    Goto, Hiroaki
    Yoshino, Yuki
    Nakamura, Wataru
    Fujita, Sachio
    Miyagawa, Naoyuki
    Hayashi, Akiko
    Yokosuka, Tomoko
    Hamanoue, Satoshi
    Iwasaki, Fuminori
    Shiomi, Masae
    Goto, Shoko
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S35 - S36
  • [8] In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia
    Lonnerholm, Gudmar
    Thorn, Ingrid
    Sundstrom, Christer
    Frost, Britt-Marie
    Flaegstad, Trond
    Heyman, Mats
    Jonsson, Olafur Gisli
    Harila-Saari, Arja
    Madsen, Hans O.
    Porwit, Anna
    Schmiegelow, Kjeld
    Soderhall, Stefan
    Wesenberg, Finn
    Vettenranta, Kim
    Larsson, Rolf
    Forestier, Erik
    LEUKEMIA RESEARCH, 2011, 35 (04) : 472 - 478
  • [9] Immunophenotype in relation to in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukemia (ALL).
    Kaspers, GJL
    Wijnands, JJM
    Hartmann, R
    Von Stackelberg, A
    Henze, G
    Pieters, R
    Hahlen, K
    Van Wering, ER
    Veerman, AJP
    BLOOD, 2003, 102 (11) : 859A - 860A
  • [10] COAGULATION FACTOR XIIIA IS A NEW PROGNOSTIC FACTOR IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Kiss, Csongor
    Csathy, Laszlo
    Szegedi, Istvan
    Kiss, Flora
    Molnar, Anna
    Hevessy, Zsuzsanna
    Kappelmayer, Janos
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1029 - 1029
12345